Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neuroprotective agents disclosed by Shionogi

July 24, 1998

Natural glutamate uptake inhibitors useful for memory disturbances

July 24, 1998

Beta-sheet breaker peptide potentially effective against amyloidosis in Alzheimer's disease

July 24, 1998

Genentech stroke study terminated due to inability to demonstrate clinical benefit

July 23, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

Phase III clinical trial results with galantamine suggest novel mechanism of action

July 23, 1998

Nortran initiates phase II trials for local anesthetic

July 23, 1998

New series of neuroprotective compounds described by Nippon Chemiphar

July 23, 1998

Inhaled analgesic available for licensing from BTG

July 23, 1998

Neurogen's epilepsy compound advances through clinical trials

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...